Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(22):1678-1679; doi:10.1093/jnci/93.22.1678
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Baltic, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baltic, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 22, 1678-1679, November 21, 2001
© 2001 Oxford University Press

NEWS

Analysis of Mammography Trials Renews Debate on Mortality Reduction

Scott Baltic

A recent Cochrane review and a related report in the Lancet have reignited the controversy about screening mammography.

Based on a major review of clinical trials addressing the issue, the conclusions of Lancet authors Ole Olsen and Peter C. Gøtzsche, M.D., were strikingly unequivocal: "In 2000, we reported that there is no available evidence that screening for breast cancer reduces mortality. As we discuss here, a Cochrane review has now confirmed and strengthened our previous findings."

The accompanying editorial by Richard . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 RadiologyHome page
E. M. Rohren, T. G. Turkington, and R. E. Coleman
Clinical Applications of PET in Oncology
Radiology, May 1, 2004; 231(2): 305 - 332.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
H. G. Juffs and I. F. Tannock
Screening Trials Are Even More Difficult Than We Thought They Were
J Natl Cancer Inst, February 6, 2002; 94(3): 156 - 157.
[Full Text] [PDF]